Literature DB >> 18566076

Should the drug industry work with key opinion leaders? No.

Giovanni A Fava1.   

Abstract

Mesh:

Year:  2008        PMID: 18566076      PMCID: PMC2432130          DOI: 10.1136/bmj.39541.731493.59

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Conflict, what conflict?

Authors:  M S Wilkes
Journal:  West J Med       Date:  2000-01

2.  Financial conflicts of interest in psychiatry.

Authors:  Giovanni A Fava
Journal:  World Psychiatry       Date:  2007-02       Impact factor: 49.548

3.  Conflicts of interest and the credibility of psychiatric research.

Authors:  Steven M Paul; Mauricio Tohen
Journal:  World Psychiatry       Date:  2007-02       Impact factor: 49.548

4.  Scientific journals and their authors' financial interests: a pilot study.

Authors:  S Krimsky; L S Rothenberg; P Stott; G Kyle
Journal:  Psychother Psychosom       Date:  1998 Jul-Oct       Impact factor: 17.659

5.  A national survey of physician-industry relationships.

Authors:  Eric G Campbell; Russell L Gruen; James Mountford; Lawrence G Miller; Paul D Cleary; David Blumenthal
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

6.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

  6 in total
  2 in total

1.  Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research.

Authors:  Jeffrey R Lacasse; Jonathan Leo
Journal:  BMC Res Notes       Date:  2011-01-31

2.  Sunshine on KOLs: assessment of the nature, extent and evolution of financial ties between the leaders of professional medical associations and the pharmaceutical industry in France from 2014 to 2019: a retrospective study.

Authors:  Marie Clinckemaillie; Alexandre Scanff; Florian Naudet; Adriaan Barbaroux
Journal:  BMJ Open       Date:  2022-02-02       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.